Disease phobia and disease conviction are separate dimensions underlying hypochondriasis

Journal of Behavior Therapy and Experimental Psychiatry
Thomas A Fergus, David P Valentiner

Abstract

The current study uses data from a large nonclinical college student sample (N = 503) to examine a structural model of hypochondriasis (HC). This model predicts the distinctiveness of two dimensions (disease phobia and disease conviction) purported to underlie the disorder, and that these two dimensions are differentially related to variables important to health anxiety and somatoform disorders, respectively. Results were generally consistent with the hypothesized model. Specifically, (a) body perception variables (somatosensory amplification and anxiety sensitivity - physical) emerged as significant predictors of disease phobia, but not disease conviction; (b) emotion dysregulation variables (cognitive avoidance and cognitive reappraisal) emerged as significant predictors of disease conviction, but not disease phobia; and (c) both disease phobia and disease conviction independently predicted medical utilization. Further, collapsing disease phobia and disease conviction onto a single latent factor provided an inadequate fit to the data. Conceptual and therapeutic implications of these results are discussed.

References

Jan 1, 1992·The Journal of Nervous and Mental Disease·A J BarskyG L Klerman
Jan 1, 1990·Journal of Psychiatric Research·A J BarskyG L Klerman
Jan 1, 1967·The British Journal of Psychiatry : the Journal of Mental Science·I Pilowsky
Nov 1, 1994·Archives of General Psychiatry·A J BarskyP D Cleary
Apr 1, 1997·Journal of Consulting and Clinical Psychology·N B SchmidtJ H Trakowski
Jul 14, 1999·Behaviour Research and Therapy·H D HadjistavropoulosG J Asmundson
Jul 10, 2002·Psychological Medicine·W HillerM M Fichter
Dec 14, 2002·Mayo Clinic Proceedings·Jonathan S AbramowitzStephen P Whiteside
Aug 15, 2003·Journal of Personality and Social Psychology·James J Gross, Oliver P John
May 20, 2004·Journal of Anxiety Disorders·Russell NoyesDouglas R Langbehn
Feb 3, 2006·International Review of Psychiatry·Elisabeth Waller, Carl Eduard Scheidt
Jun 5, 2007·Journal of Anxiety Disorders·Kathryn A Sexton, Michel J Dugas
Jun 15, 2007·Psychological Assessment·Steven TaylorSamuel Jurado Cardenas
May 20, 2008·Psychological Medicine·E Ferguson
Apr 3, 2009·Journal of Anxiety Disorders·Thomas A Fergus, David P Valentiner
May 30, 2009·The British Journal of Psychiatry : the Journal of Mental Science·Bunmi O OlatunjiJonathan S Abramowitz
Jun 30, 2009·Journal of Anxiety Disorders·Patrick G WelchGordon J G Asmundson
Apr 1, 2007·Multivariate Behavioral Research·Joost R van GinkelKlaas Sijtsma

❮ Previous
Next ❯

Citations

May 2, 2013·Journal of Behavioral Medicine·Karni GinzburgRuth Defrin
May 30, 2012·Aging & Mental Health·Lindsay A Gerolimatos, Barry A Edelstein
Feb 26, 2013·International Journal of Behavioral Medicine·Stefanie M GörgenMichael Witthöft
Jan 4, 2013·The British Journal of Psychiatry : the Journal of Mental Science·Vladan Starcevic
Feb 7, 2013·International Review of Psychiatry·Laura Sirri, Giovanni A Fava
Jun 5, 2012·Behaviour Research and Therapy·S Rachman
Oct 19, 2013·Journal of Behavior Therapy and Experimental Psychiatry·Robert E Brady, Jeffrey M Lohr
Dec 12, 2013·Anxiety, Stress, and Coping·Florian WeckSonja Rohrmann
Jul 23, 2016·The British Journal of Psychiatry : the Journal of Mental Science·Rahil SanatiniaBarbara Barrett
Sep 30, 2016·Cognitive Behaviour Therapy·Joseph R BardeenHolly K Orcutt
Dec 3, 2013·The Australian and New Zealand Journal of Psychiatry·Vladan Starcevic
Apr 27, 2017·Clinical Psychology & Psychotherapy·Josef BailerDaniela Mier
Jul 28, 2012·International Psychogeriatrics·Lindsay A Gerolimatos, Barry A Edelstein
Jan 1, 2015·Journal of Cognitive Psychotherapy·Thomas A FergusHolly K Orcutt
Jun 28, 2018·Journal of Clinical Psychology in Medical Settings·Caleb M PardueErnest V Gervino
Jun 29, 2021·International Journal of Cognitive Therapy·Juliana M B KhouryKim MacLean

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Related Papers

Behaviour Research and Therapy
Jonathan S Abramowitz, Elizabeth L Moore
Behaviour Research and Therapy
H M Warwick, Paul Salkovskis
© 2021 Meta ULC. All rights reserved